Harrow Health(IMMY)

Imprimis Pharmaceuticals和 Compounding Pharmacy

淘沙见金2017-10-30 11:45

这个制药公司Imprimis Pharmaceuticals $Imprimis Pharmaceuticals, Inc.(IMMY)$ 大涨，原因是因为公司称将会提供比AGN的干眼症治疗药物Restasis更为便宜的替代选择。这个药物第一个月只需要不到1美元，以后每个月花费79美元。对比Restasis每年的花费高达5000美元一年确实便宜不少。听起来很美好...查看全文

Vodka配鱼油救命药2017-10-20 09:45

$Imprimis Pharmaceuticals, Inc.(IMMY)$
IMMY买入原因：今天IMMY发的干眼症药物为Restasis的仿制药，RESTASIS 2016年第三季度全球销售额为371.6million, 第四季度全球销售额393.1 million占干眼症市场的80%，现有竞争对手仅有Shire’s idra，占20%的市场。IMMY的仿制药由于是走低价路线，有可...查看全文

TLS美股研究2017-04-09 21:31

回复@panderson: $IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 我们看看。我刚打赏了这条评论 ¥2.88，也推荐给你。//@panderson:回复@TLS美股研究:IMMY值得关注，眼科市场天花板逐渐打开，公司高管参与增发，市值迷你，会是小黑马吗 查看全文

$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ EFFECT - Notice of Effectiveness Filed: 2017-01-30 AccNo: 9999999995-17-000234 Size: 1 KB 网页链接

$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2017-01-30 AccNo: 0001493152-17-000934 Size: 607 KB 网页链接

$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2017-01-23 AccNo: 0001493152-17-000737 Size: 798 KB 网页链接

$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ D - Notice of Exempt Offering of Securities Filed: 2016-12-30 AccNo: 0001493152-16-016310 Size: 12 KB 网页链接

$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2016-12-29 AccNo: 0001493152-16-016261 Size: 183 KBItem 1.01: Entry into a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangemen...

$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2016-12-23 AccNo: 0001493152-16-016187 Size: 630 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 9.01: Financial Statements and Exhibits 网页链接

$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 内部交易: 2016-12-19,CEO,BAUM MARK L ,买入,156000普通股, $1.79

$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 内部交易: 2016-12-19,CEO,BAUM MARK L ,期权,200000普通股, $1.72

$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 内部交易: 2016-12-19,CFO,BOLL ANDREW R. ,买入,39000普通股, $1.79

$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 内部交易: 2016-12-19,Director,LINDSTROM RICHARD L MD ,买入,100000普通股, $1.79